These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1244920)

  • 1. Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.
    Ihde DC; DeVita VT; Canellos GP; Young RC
    Blood; 1976 Feb; 47(2):211-22. PubMed ID: 1244920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas.
    Schreiber DP; Jacobs C; Rosenberg SA; Cox RS; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):31-6. PubMed ID: 3838166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
    Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
    Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
    Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
    Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease and non-Hodgkin's lymphoma--the surgeon's role in therapy.
    Trueblood HW; Guernsey JM; Cohn R
    Curr Probl Surg; 1972 Aug; ():1-36. PubMed ID: 4564867
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy of non-Hodgkin's lymphomas in relapse.
    Klener P; Donner L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):36-40. PubMed ID: 6157622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
    Br Med J; 1975 Aug; 3(5980):413-4. PubMed ID: 1098721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 9. Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
    Bloomfield CD; Weiss RB; Fortuny I; Vosika G; Kennedy BJ
    Cancer; 1976 Jul; 38(1):42-8. PubMed ID: 947533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease.
    Tubiana M; Mathé G
    Ser Haematol; 1973; 6(2):202-43. PubMed ID: 4206180
    [No Abstract]   [Full Text] [Related]  

  • 11. Splenectomy effects on chemotherapy in Hodgkin's disease.
    Panettiere F; Coltman CA
    Arch Intern Med; 1973 Mar; 131(3):362-6. PubMed ID: 4688035
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy for stage IV Hodgkin's disease (Report no 14).
    Goldman JM
    Clin Radiol; 1981 Sep; 32(5):531-6. PubMed ID: 6168426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated Hodgkin's disease. C. Advanced disease and special problems. Combined chemotherapy-radiotherapy program.
    Fuller LM; Gamble JF
    JAMA; 1973 Jan; 223(2):168-9. PubMed ID: 4739457
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
    Fiacchini M; Lauria F; Mazza P; Tura S
    Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hodgkin's disease: classification, staging, therapy].
    Wewerka JR
    Schweiz Med Wochenschr; 1978 Aug; 108(32):1241-6. PubMed ID: 150029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early results of combined treatment in Hodgkin's disease with nitrogen mustard, vincristine, Natulan and prednisone (MOPP treatment)].
    Zelechowska JA; Madej G; Piemkowska F
    Nowotwory; 1976; 26(3):163-70. PubMed ID: 980801
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of Hodgkin's and non-Hodgkin's lymphomas.
    Sahakian GJ
    Med Clin North Am; 1975 Mar; 59(2):387-97. PubMed ID: 1117771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisone in MOPP chemotherapy for Hodgkin's disease.
    Jacobs C; Portlock CS; Rosenberg SA
    Br Med J; 1976 Dec; 2(6050):1469-71. PubMed ID: 1000259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
    Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
    Dtsch Med Wochenschr; 1976 Aug; 101(32):1177-82. PubMed ID: 59661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy of advanced Hodgkin's disease. A review.
    Goldsmith MA; Carter SK
    Cancer; 1974 Jan; 33(1):1-8. PubMed ID: 4129559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.